On August 15th at 8:00 PM, Smore technology announced through its official public account, "Smore Technology", that their Smore Analysis and Testing Center for Security Assessment has received accreditation from Eurofins, a global leader in scientific analysis and testing certification, for their CTF laboratory.
Eurofins is an internationally recognized testing and certification institution with over 900 laboratories in 54 countries worldwide. They specialize in various fields including power batteries, medical devices, explosion-proof products, and industrial machinery, utilizing over 200,000 reliable analysis methods. With an impressive 450 million tests conducted annually, Eurofins is highly regarded in their industry.
The image is sourced from SIMO Technology's official public account.
According to reports, Eurofins has assessed and audited the CTF accredited laboratory for its SEMI analysis testing and safety evaluations in accordance with IECEE's requirements. The laboratory has been issued a certification of accreditation by Eurofins.
CTF, also known as Customer Testing Facilities, refers to a laboratory for testing electrical products. Smoltech has recently completed the IECEE-CB (the mutual recognition system for testing electrical products) Scheme CTF certification. After receiving this certification, Smoltech's safety tests can be mutually recognized by the 54 IECEE member countries globally. Following the unveiling of the CTF laboratory certification, customers from all over the world can access Smoltech's CTF laboratory on the IEC website. They can directly indicate the name and address of the laboratory in globally recognized CB reports.
Furthermore, Summor Analysis Testing and Safety Assessment Center also undertakes market access testing for electronic vaporizer products including the US PMTA and EU TPD.
This article contains excerpts or reprints from third-party sources. The copyright belongs to the original media and author. If there is any infringement, please contact us for removal. Any individual or organization wishing to reprint should contact the author and not republish directly.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
